Multiple myeloma: the quality of care is linked to geographical and organisational determinants. A study in a French registry.

about

P2860

Q38692424-D2A1E769-448A-415A-BF7D-43E81804AB34

P2860

Multiple myeloma: the quality of care is linked to geographical and organisational determinants. A study in a French registry.

Item

http://www.wikidata.org/entity/Q40279004

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Multiple myeloma: the quality ...... A study in a French registry.

@en

type

Item

label

Multiple myeloma: the quality ...... A study in a French registry.

@en

prefLabel

Multiple myeloma: the quality ...... A study in a French registry.

@en

P1476

Multiple myeloma: the quality ...... A study in a French registry.

@en

P2093

G Defossez

http://www.w3.org/2001/XMLSchema#string

P Ingrand

http://www.w3.org/2001/XMLSchema#string

P2860

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry.

Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.

VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA s

Multiple myeloma: causes and consequences of delay in diagnosis.

Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in sweden.

Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

P304

855-863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ECC.12414

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

François Guilhot

M Puyade

P577

2015-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284718817

http://www.w3.org/2001/XMLSchema#string

P698

26603508

http://www.w3.org/2001/XMLSchema#string

Multiple myeloma: the quality of care is linked to geographical and organisational determinants. A study in a French registry.

about

P2860

P2860

Multiple myeloma: the quality of care is linked to geographical and organisational determinants. A study in a French registry.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698